Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Income Statements (Unaudited)

v3.26.3
Condensed Consolidated Income Statements (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue        
Total revenue $ 55,480 $ 40,430 $ 163,843 $ 117,430
Cost of sales
Gross profit 55,480 40,430 163,843 117,430
Selling, general and administrative expenses 209,167 201,114 709,754 598,821
Operating income (loss) (153,687) (160,684) (545,911) (481,391)
Other income and (expense)        
Legal recovery of previously impaired investment 175,361 175,361
Interest income 3,742 3,897 3,935 40,940
Unrealized gain (loss) on investment in securities (1,112) 87,520 (69,255) 115,314
Gain (loss) on sale of investment in securities 24,304 43,044 (185,147)
Gain (loss) on sale of investment in gold 49,886
 Gain (loss) on sale of investment in futures 116
Other income (expenses) 5 20,418
Total other income and (expense) 202,300 91,417 223,505 (28,893)
Income (loss) before provision for income taxes 48,613 (69,267) (322,406) (510,284)
Provision for income taxes (4,435) (4,443)
Net income (loss) $ 48,613 $ (69,267) $ (326,841) $ (514,727)
Basic and diluted net income (loss) per common share:        
Basic $ 0.0018 $ (0.0032) $ (0.0130) $ (0.0237)
Diluted [1] $ 0.0017 $ (0.0032) $ (0.0130) $ (0.0237)
Weighted average number of shares of common stock outstanding:        
Basic 27,589,296 21,686,105 25,226,853 21,686,105
Diluted [1] 29,097,361 21,686,105 25,226,853 21,686,105
Royalty [Member]        
Revenue        
Total revenue $ 55,480 $ 40,430 $ 163,843 $ 117,430
[1] In periods when the Company recorded an operating loss, the diluted EPS was not calculated as the diluted EPS effect is anti-dilutive.